Exhaled air volatile organic compounds and eosinophilic airway inflammation in asthma

A.H. Wagener, A.H. Zwinderman, R. Lutter, S. de Koning, H.G. Janssen, R.G. Knowles, A. Sousa, E.H. Bel, P.J. Sterk (Amsterdam, Netherlands; Mönchengladbach, Germany; Stevenage, United Kingdom)

Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma
Session: Clinical diagnosis and treatment of adult asthma
Session type: Oral Presentation
Number: 4695
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A.H. Wagener, A.H. Zwinderman, R. Lutter, S. de Koning, H.G. Janssen, R.G. Knowles, A. Sousa, E.H. Bel, P.J. Sterk (Amsterdam, Netherlands; Mönchengladbach, Germany; Stevenage, United Kingdom). Exhaled air volatile organic compounds and eosinophilic airway inflammation in asthma. Eur Respir J 2012; 40: Suppl. 56, 4695

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma
Source: Eur Respir J 2007; 29: 676-681
Year: 2007



Gas and dust exposure in underground construction is associated with signs of airway inflammation
Source: Eur Respir J 2001; 17: 416-421
Year: 2001



Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002



Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011



Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Exhaled volatile organic compounds as markers for medication use in asthma
Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019
Year: 2020



Volatile organic chemicals contribute to airway hyperresponsiveness
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003

Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Exhaled volatile organic compounds in nonrespiratory diseases
Source: Eur Respir Monogr 2010; 49: 140-151
Year: 2010


Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009


Exhaled NO and bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 280s
Year: 2005

Measurement of exhaled gases in chronic airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


Exhaled NO, small airway obstruction and airway hyper-responsiveness in pediatric asthma
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Exhaled markers in the monitoring of airways inflammation in mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 679s
Year: 2004